Navigation Links
International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
Date:4/28/2011

MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter ablation for the treatment of paroxysmal AF.  The event followed the first day of the German Society for Cardiology Annual Meeting in Mannheim, Germany.

The symposium, "Does Optical Visualization Help to Improve the Durability of Pulmonary Vein Isolation?,"  was co-chaired by renowned electrophysiologists Prof. Karl-Heinz Kuck, MD, of Krankenhaus St. Georg, Hamburg, Germany, and Petr Neuzil, MD, of Na Homolce Hospital, Prague, Czech Republic. The clinical experience of three leading centers was presented examining the use of the CardioFocus Endoscopic Ablation System, a unique compliant balloon ablation catheter able to deliver, visually guided laser energy to achieve durable pulmonary vein isolation (PVI) after only a single clinical procedure.

"It is broad industry consensus that permanent control of paroxysmal atrial fibrillation requires that the pulmonary veins must be permanently isolated.  However, conventional point-to-point ablation done without optical visualization offers only limited efficacy and requires multiple procedures," remarked Stephen Sagon, President and CEO of CardioFocus, Inc. "We are pleased that our Endoscopic Ablation System technology is being recognized by international leaders in the field as a solution that meets significant clinical needs. The HeartLight catheter from CardioFocus offers electrophysiologists unique endocardial visualization to provide better outcomes from a single procedure."

The German Symposium highlighted promising independent results from St. Georg (Hamburg) presented by Andreas Metzner, MD, and from the Institute for Clinical & Experimental Medicine (Prague) presented by Prof. Josef Kautzner, MD, PhD.  This research included long-term results validated by remapping. Using the CardioFocus Endoscopic Ablation System, the rate of acute isolation of the pulmonary veins has been reported at 99% in several published, peer reviewed articles. Chronic pulmonary vein isolation has also been reported to be near 90% when assessed at three months.

Also featured were results from "Pulmonary Vein Isolation Using the Visually-Guided Laser Balloon: The First 200-Patient Multicenter Clinical Experience in Europe and US," previewed by Boris Schmidt, MD of Cardioangiologisches Centrum Bethanien of Frankfurt, Germany. Full results from this study will be presented at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions, Friday, May 6, 2011.

About CardioFocus, Inc.CardioFocus, Inc. is a medical device manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF). Its novel Endoscopic Ablation System incorporates a catheter containing both a micro-endoscope and light energy fibers to give physicians the capacity to see within the heart, and for the first time, visually direct the application of laser energy to achieve durable pulmonary vein isolation.

The CardioFocus Endoscopic Ablation System received CE Mark in 2009 for the treatment of atrial fibrillation, and is commercially available at key institutions throughout Europe. The device is investigational in the U.S., with a pivotal study expected to commence in 2011. CardioFocus is headquartered in Marlborough, MA.  For more information on the company and its technology, please visit www.CardioFocus.com.

The scientific information discussed in this news release is preliminary and investigative. The CardioFocus Endoscopic Ablation System is not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the system. Only FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Healthcare professionals should refer to/rely upon FDA-approved labeling for the products, and not the information discussed in this news release.Company Contact:

Media Contact:Anjie Roldan

Lisa Cook/ Jason Rando Vice President Finance(646) 536-7012/7025(508) 658-7237

lcook@theruthgroup.com  aroldan@cardiofocus.com

jrando@theruthgroup.com
'/>"/>

SOURCE CardioFocus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mettler-Toledo International Inc. to Host First-Quarter 2011 Earnings Conference Call
2. NxStage® Names Michael Miller, Jr. President, International
3. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
4. CIVCOs Protura™ and Universal Couchtop™ Installed at U.S. and International Cancer Centers
5. Worlds Leaders on Macular Disease Convene in New York on April 16 for AMD Alliance International (AMDAI) Meeting
6. Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study
7. PRA International Experts to Speak at Drug Safety Conference
8. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
9. Mauna Kea Technologies Announces Highlights of Third International Conference of Cellvizio Users (ICCU)
10. Two New U.S. Patents Issued to Dyadic International
11. Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
(Date:6/23/2016)... , June 23, 2016  Experian Health, ... and transforming the patient payment and care ... innovative new products and services that will ... revenue cycle offerings. These award-winning solutions will ... workflows, remain compliant in an ever-changing environment ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):